What is LOPJLB’s current signal on IRLA?

LOPJLB’s latest quantitative signal on Quince Therapeutics, Inc. (IRLA) is BUY in a RECOVERY regime. Signals are updated daily.

What market regime is IRLA in?

Quince Therapeutics, Inc. (IRLA) is currently classified in the RECOVERY HMM market regime on LOPJLB.

What does Quince Therapeutics, Inc. (IRLA) do?

Quince Therapeutics, Inc., a biotechnology company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. The company's lead asset candidature comprises eDSP, which is in Phase 3, for the treatment of rare pediatric neurodegenerative disease, including A-T, an inherited autosomal recessive neurodegenerative and immunodeficiency diso…

Quince Therapeutics, Inc. (IRLA)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$32.40+13.68%Close

BUYRECOVERY · day 3

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Market cap: $33M

1W: +20.85%
1M: +13.33%

vs SPY 1W: +20.43%
vs SPY 1M: +11.27%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

FAQ

What is LOPJLB’s current signal on IRLA?: LOPJLB’s latest quantitative signal on Quince Therapeutics, Inc. (IRLA) is BUY in a RECOVERY regime. Signals are updated daily.
What market regime is IRLA in?: Quince Therapeutics, Inc. (IRLA) is currently classified in the RECOVERY HMM market regime on LOPJLB.
What does Quince Therapeutics, Inc. (IRLA) do?: Quince Therapeutics, Inc., a biotechnology company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. The company's lead asset candidature comprises eDSP, which is in Phase 3, for the treatment of rare pediatric neurodegenerative disease, including A-T, an inherited autosomal recessive neurodegenerative and immunodeficiency diso…

Key stats

Prediction markets

Company news

FAQ